oncology

Showing 15 posts of 328 posts found.

fighting_cancer

Looking to the future of oncology

April 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …

medimmune_building_cambridge

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …

celgene_1_02

Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory

March 5, 2018
Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma

Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …

merckincweb

MSD poised to acquire viral immuno-oncology firm Viralytics for $394m

February 21, 2018
Research and Development, Sales and Marketing Cancer, MSD, Merck, Viralytics, acquisition, keytruda, oncology, pharma

MSD, known as Merck in the US, has announced it is to buy Australian viral immuno-oncology firm Viralytics for $394 …

Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health

February 16, 2018
Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma

Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …

Old anti-drinking drug shows potential as cancer treatment

December 7, 2017
Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical

Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …

portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

EMA responds to criticism of its cancer drug approvals

October 17, 2017
Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical

The EMA received a broadside just less than two week ago from a group of researchers that had studied data …

ema_interior

57% of cancer drugs uses approved by EMA show no benefit

October 5, 2017
Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical

A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …

Takeda reveals collaboration aimed at bolstering oncology pipeline

August 8, 2017
Manufacturing and Production, Sales and Marketing Molecular Templates, Takeda, biotech, drugs, oncology, pharma, pharmaceutical

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …

shutterstock_212035546

Investigational antibody boosts chemotherapy’s cancer-killing potential

June 29, 2017
Research and Development CFH, Cancer, oncology, rituximab

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …

shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017
Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …

cancer_cells

ICR track cancer to ‘carbon date’ progression

May 11, 2017
Research and Development Cancer, ICR, bowel cancer, oncology

The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease …

The Gateway to Local Adoption Series

Latest content